Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice.

MacLeod SH, Elgadi MM, Bossi G, Sankar U, Pisio A, Agopsowicz K, Sharon D, Graham FL, Hitt MM.

Cancer Gene Ther. 2012 Dec;19(12):888-98. doi: 10.1038/cgt.2012.79. Epub 2012 Oct 26.

PMID:
23099884
2.
3.

Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs.

Logunov DY, Zubkova OV, Karyagina-Zhulina AS, Shuvalova EA, Karpov AP, Shmarov MM, Tutykhina IL, Alyapkina YS, Grezina NM, Zinovieva NA, Ernst LK, Gintsburg AL, Naroditsky BS.

J Virol. 2007 Sep;81(18):9641-52. Epub 2007 Jun 27.

4.

Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.

Van Houdt WJ, Wu H, Glasgow JN, Lamfers ML, Dirven CM, Gillespie GY, Curiel DT, Haviv YS.

Neuro Oncol. 2007 Jul;9(3):280-90. Epub 2007 May 23.

6.

Small-animal SPECT/CT of HER2 and HER3 expression in tumor xenografts in athymic mice using trastuzumab Fab-heregulin bispecific radioimmunoconjugates.

Razumienko EJ, Scollard DA, Reilly RM.

J Nucl Med. 2012 Dec;53(12):1943-50. doi: 10.2967/jnumed.112.106906. Epub 2012 Oct 24.

7.

Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system.

Stoff-Khalili MA, Stoff A, Rivera AA, Mathis JM, Everts M, Wang M, Kawakami Y, Waehler R, Mathews QL, Yamamoto M, Rocconi RP, Siegal GP, Richter DF, Dall P, Zhu ZB, Curiel DT.

Cancer Biol Ther. 2005 Nov;4(11):1203-10. Epub 2005 Nov 8.

PMID:
16177567
8.

Adenovirus fiber shaft contains a trimerization element that supports peptide fusion for targeted gene delivery.

Li J, Lad S, Yang G, Luo Y, Iacobelli-Martinez M, Primus FJ, Reisfeld RA, Li E.

J Virol. 2006 Dec;80(24):12324-31. Epub 2006 Oct 4.

9.

Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies.

Rittner K, Schreiber V, Erbs P, Lusky M.

Cancer Gene Ther. 2007 May;14(5):509-18. Epub 2007 Feb 23.

PMID:
17318198
10.

Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors.

Haviv YS, Blackwell JL, Kanerva A, Nagi P, Krasnykh V, Dmitriev I, Wang M, Naito S, Lei X, Hemminki A, Carey D, Curiel DT.

Cancer Res. 2002 Aug 1;62(15):4273-81.

11.

A functional comparison between the HER2(high)/HER3 and the HER2(low)/HER3 dimers on heregulin-β1-induced MMP-1 and MMP-9 expression in breast cancer cells.

Kim S, Han J, Shin I, Kil WH, Lee JE, Nam SJ.

Exp Mol Med. 2012 Aug 31;44(8):473-82. doi: 10.3858/emm.2012.44.8.054.

12.

Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.

Lammering G, Lin PS, Contessa JN, Hampton JL, Valerie K, Schmidt-Ullrich RK.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):775-84.

PMID:
11697324
13.

Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells.

Von Seggern DJ, Huang S, Fleck SK, Stevenson SC, Nemerow GR.

J Virol. 2000 Jan;74(1):354-62.

14.

Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma.

Chen W, Wu Y, Liu W, Wang G, Wang X, Yang Y, Chen W, Tai Y, Lu M, Qian Q, Zhang Q, Chen G.

Cancer Lett. 2011 Aug 1;307(1):93-103. doi: 10.1016/j.canlet.2011.03.021. Epub 2011 Apr 19.

PMID:
21504839
15.

Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers.

Zhao Y, Li Y, Wang Q, Wang L, Yang H, Li M.

Mol Cell Biochem. 2011 Jul;353(1-2):93-9. doi: 10.1007/s11010-011-0778-5. Epub 2011 Mar 25.

PMID:
21437625
16.

Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.

Kanerva A, Mikheeva GV, Krasnykh V, Coolidge CJ, Lam JT, Mahasreshti PJ, Barker SD, Straughn M, Barnes MN, Alvarez RD, Hemminki A, Curiel DT.

Clin Cancer Res. 2002 Jan;8(1):275-80.

17.

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.

Kanerva A, Wang M, Bauerschmitz GJ, Lam JT, Desmond RA, Bhoola SM, Barnes MN, Alvarez RD, Siegal GP, Curiel DT, Hemminki A.

Mol Ther. 2002 Jun;5(6):695-704.

18.

Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivo.

Seki T, Dmitriev I, Suzuki K, Kashentseva E, Takayama K, Rots M, Uil T, Wu H, Wang M, Curiel DT.

Gene Ther. 2002 Aug;9(16):1101-8.

19.

Adenovirus-mediated tissue-targeted expression of the CDglyTk gene for the treatment of breast cancer.

Su GQ, Su G, Huang ZH.

Mol Med Rep. 2012 Aug;6(2):321-9. doi: 10.3892/mmr.2012.925. Epub 2012 May 23.

PMID:
22641384
20.

Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.

Grill J, Van Beusechem VW, Van Der Valk P, Dirven CM, Leonhart A, Pherai DS, Haisma HJ, Pinedo HM, Curiel DT, Gerritsen WR.

Clin Cancer Res. 2001 Mar;7(3):641-50.

Supplemental Content

Support Center